Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hodgkin's disease lymphocyte predominance type stage unspecified
ADR ID BADD_A02087
ADR Hierarchy
01      Blood and lymphatic system disorders
01.16      Lymphomas Hodgkin's disease
01.16.04      Hodgkin's disease lymphocyte predominance type
01.16.04.001      Hodgkin's disease lymphocyte predominance type stage unspecified
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.31      Lymphomas Hodgkin's disease
16.31.04      Hodgkin's disease lymphocyte predominance type
16.31.04.001      Hodgkin's disease lymphocyte predominance type stage unspecified
Description Not Available
MedDRA Code 10020231
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Hodgkin's disease lymphocyte predominance type stage unspecified | Hodgkin's disease, lymphocytic-histiocytic predominance | Hodgkin's paragranuloma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00195Azathioprine--
BADD_D00497Clomiphene--
BADD_D00551Cyclosporine--
BADD_D01352Maraviroc--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01386Mephenytoin--
BADD_D01765Phenytoin--
BADD_D02192Thalidomide--
The 1th Page    1    Total 1 Pages